The use case: how Novo Nordisk deploys Celonis
Novo Nordisk built a digital twin of its clinical trials application process in Celonis and uses Celonis Process Intelligence to power a fleet of AI agents that automate regulated clinical development workflows. It also uses the platform to diagnose whether problems lie in people, process or technology and to validate KPIs during IT modernization.
In the customer’s words
Without Process Intelligence, Enterprise AI at scale is hopeful thinking.Other AI tools used by Novo Nordisk
Other public relationships recorded on usedby.
Explore Novo Nordisk’s AI stackCelonis users in Biotech & Pharma
Companies in the same sector, with public evidence.
See all Celonis customersGo straight to the source
Based on Celonis’s published case study. We check the public evidence; the results are reported by the vendor.
celonis.com- Last checked
- Oct 8, 2026
Open source capture What the story claims, and what we checked
What we compared with the page.
- The figure: 100+Checked
The figure is on the page; its label is our wording.
- The passage quoted aboveChecked
Copied word for word from the page, near the name of Novo Nordisk.
- Novo Nordisk uses CelonisChecked
Confirmed line.
- The result itselfNot checked
We quote it; we did not measure it.
Today, Novo Nordisk are transforming into an agentic enterprise. They’re powering a fleet of over 100 AI agents with Celonis to revolutionize clinical development. The ambition: shaving 12 months or more off drug development time to get medications into the hands of patients faster.










